Picture of Mitsui Chemicals logo

4183 — Mitsui Chemicals News Story

0.000.00%
jp flag iconLast trade - 00:00
Basic MaterialsBalancedLarge CapSuper Stock

In Japan chip deal, everyone wins except the buyer

BREAKINGVIEWS-In Japan chip deal, everyone wins except the buyer

The author is a Reuters Breakingviews columnist. The opinions expressed are his own. Updates with graphics and hyperlinks.

By Hudson Lockett

- Like a salmon trying to swallow a shark, Mitsui Chemicals' 4183.T eyes for its agreed deal look far bigger than its stomach. The $3.8 billion Japanese chemical supplier’s purchase of chip materials firm JSR from Japan Investment Corp stands to enhance the global competitiveness of the country's supply chain in a strategic industry. The transaction will also deliver a windfall for the state-backed seller, which only agreed to acquire it three years ago. But it will stretch the buyer’s balance sheet and, should the AI and semiconductor cycles turn before synergies arrive, prove a recipe for lasting indigestion.

The size differential between Mitsui and its target has widened substantially since Reuters identified JIC’s chosen buyer and potential price on November 4, with an 8% drop on Monday taking the acquiror's shares 24% lower over a week. That tots up to an enterprise value of 1.45 trillion yen ($9.2 billion) for Mitsui, compared to the 1.84 trillion yen for JSR. The offer will require 200 billion yen in financing from the Development Bank of Japan, plus equity issuance from the buyer worth 150 billion yen, with the remainder covered by mezzanine financing and debt.

And while full financial details for the unlisted target aren’t available, figures provided by Mitsui on JSR’s recent performance imply the deal values the target’s enterprise at a multiple of more than four times sales for the year through March 2026. That's a far richer valuation than its own multiple of less than one – and a solid improvement on the roughly two times JIC agreed in 2023 when it took the manufacturer of photoresists, used in semiconductor etching, private for about 904 billion yen, about $6 billion at the time.

Another issue lies in how long the deal's growth and cost synergies will take to come good. Mitsui only aims to achieve annual incremental profit of about 40 billion yen by fiscal year 2035. That is plenty of time for the AI-driven boom in data centre construction to come further off the boil, undermining the acquisition's contribution to the company's bottom line. And in the meantime the buyer expects it will take three years to get its net debt to equity ratio back below 1.5 times, even with 50% of mezzanine financing recognised as equity, compared to a previous target ceiling of 0.8 times. Little wonder that investors scrambled for the exit upon learning the deal's details, and it is hard to imagine there won't be an objection or two from those who remain.

Follow Hudson Lockett on Bluesky and X.

CONTEXT NEWS

Mitsui Chemicals said on November 9 that it will acquire chipmaking materials producer JSR from state-backed fund Japan Investment Corp for 1.84 trillion yen.

To raise funds to support the deal, the buyer will issue equity worth 150 billion yen, or about $950 million. The rest will be funded by a mixture of mezzanine financing and debt.

Shares in Mitsui Chemicals closed down 8.5% following the announcement on November 9. That took cumulative losses to 23.4% since November 4, when Reuters reported that JIC planned to sell JSR to the listed chemicals producer in a deal that could exceed 1.3 trillion yen.

The deal is expected to close in the second half of the fiscal year ending March 2028, pending regulatory and other approvals.


(Editing by Una Galani; Production by Eileen Soreng and Aditya Srivastav)

((For previous columns by the author, Reuters customers can click on LOCKETT/ hudson.lockett@thomsonreuters.com))

Recent news on Mitsui Chemicals

See all news